ARID1A serves as a receivable biomarker for the resistance to EGFR-TKIs in non-small cell lung cancer

• প্রধান লেখক: Dantong Sun (লেখক), Fei Teng (লেখক), Puyuan Xing (লেখক), Junling Li (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: BMC, 2021-10-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Abstract ARID1A is a key component of the SWI/SNF chromatin remodeling complexes which is important for the maintaining of biological processes of cells. Recent studies had uncovered the potential role of ARID1A alterations or expression loss in the therapeutic sensitivity of cancers, but the studie...